A detailed history of Gables Capital Management Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Gables Capital Management Inc. holds 2,285 shares of ABT stock, worth $271,001. This represents 0.13% of its overall portfolio holdings.

Number of Shares
2,285
Previous 2,285 -0.0%
Holding current value
$271,001
Previous $237,000 9.7%
% of portfolio
0.13%
Previous 0.13%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

SELL
$100.73 - $112.44 $37,068 - $41,377
-368 Reduced 13.87%
2,285 $237,000
Q4 2023

Feb 07, 2024

SELL
$90.19 - $110.4 $3,787 - $4,636
-42 Reduced 1.56%
2,653 $292,000
Q2 2023

Aug 02, 2023

BUY
$100.78 - $112.29 $15,117 - $16,843
150 Added 5.89%
2,695 $293,000
Q2 2021

Aug 03, 2021

SELL
$105.79 - $124.53 $102,616 - $120,794
-970 Reduced 27.6%
2,545 $295,000
Q4 2020

Feb 03, 2021

SELL
$105.0 - $114.42 $105,000 - $114,420
-1,000 Reduced 22.15%
3,515 $385,000
Q3 2020

Nov 12, 2020

BUY
$91.64 - $111.29 $91,640 - $111,290
1,000 Added 28.45%
4,515 $491,000
Q4 2019

Feb 10, 2020

SELL
$78.51 - $87.4 $23,553 - $26,220
-300 Reduced 7.86%
3,515 $305,000
Q3 2019

Oct 30, 2019

BUY
$81.84 - $88.74 $79,384 - $86,077
970 Added 34.09%
3,815 $319,000
Q1 2019

Apr 30, 2019

BUY
$66.22 - $80.06 $6,290 - $7,605
95 Added 3.45%
2,845 $227,000
Q4 2018

Feb 08, 2019

SELL
$65.56 - $74.27 $6,228 - $7,055
-95 Reduced 3.34%
2,750 $199,000
Q1 2018

May 17, 2018

BUY
$56.27 - $63.62 $160,088 - $180,998
2,845 New
2,845 $170,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $208B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Gables Capital Management Inc. Portfolio

Follow Gables Capital Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gables Capital Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Gables Capital Management Inc. with notifications on news.